Immediate Impact
1 from Science/Nature 40 standout
Citing Papers
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
Works of Michael Murphy being referenced
Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines
2023
Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael Murphy | 34 | 35 | 25 | 39 | 38 | 22 | 221 | |
| Predrag Sazdanović | 39 | 19 | 47 | 25 | 33 | 36 | 284 | |
| Jean‐Baptiste Meynard | 13 | 11 | 37 | 34 | 51 | 22 | 290 | |
| Amy Edwards | 25 | 12 | 19 | 42 | 26 | 21 | 249 | |
| Veronica Fitzpatrick | 12 | 19 | 32 | 64 | 31 | 27 | 298 | |
| Yasna Rostam‐Abadi | 49 | 17 | 12 | 64 | 40 | 25 | 257 | |
| Rita Nagy | 37 | 46 | 26 | 29 | 10 | 34 | 207 | |
| Kristin Weaver | 21 | 11 | 33 | 47 | 14 | 34 | 273 | |
| Niamh Keating | 83 | 19 | 8 | 25 | 74 | 17 | 237 | |
| J. Eigler | 23 | 84 | 13 | 25 | 70 | 27 | 265 | |
| Phulen Sarma | 13 | 20 | 58 | 45 | 43 | 19 | 268 |
All Works
Login with ORCID to disown or claim papers
Loading papers...